Co - expression of NRP1 and ( VEGFR - 2) KDR on the surface of endothelial cells ( EC) enhances VEGF165 binding to KDR and EC chemotaxis in response to VEGF165.	"NRP1	19	23	Gene_or_gene_product"	"VEGFR - 2	30	39	Gene_or_gene_product"	"KDR	41	44	Gene_or_gene_product"	"surface	52	59	Cellular_component"	"endothelial cells	63	80	Cell"	"EC	83	85	Cell"	"VEGF165	96	103	Gene_or_gene_product"	"KDR	115	118	Gene_or_gene_product"	"EC	123	125	Cell"	"VEGF165	152	159	Gene_or_gene_product"	"[{""token"": ""NRP1"", ""start_span"": 19, ""end_span"": 23, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEGFR - 2"", ""start_span"": 30, ""end_span"": 39, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Gene_or_gene_product""}, {""token"": ""surface"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Cellular_component""}, {""token"": ""endothelial cells"", ""start_span"": 63, ""end_span"": 80, ""type"": ""Cell""}, {""token"": ""EC"", ""start_span"": 83, ""end_span"": 85, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 96, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""KDR"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""EC"", ""start_span"": 123, ""end_span"": 125, ""type"": ""Cell""}, {""token"": ""VEGF165"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}]"
Following cotransfection of p53 - null EU - 4 cells with survivin promoter - luciferase constructs and either wt - p53 or different mut - p53 expression vectors, wt - p53 inhibited survivin promoter activity; p53 - mediated inhibition could be abrogated by overexpression of murine double minute2 ( MDM2) protein.	"p53	28	31	Gene_or_gene_product"	"survivin	57	65	Gene_or_gene_product"	"luciferase	77	87	Gene_or_gene_product"	"p53	115	118	Gene_or_gene_product"	"p53	138	141	Gene_or_gene_product"	"p53	167	170	Gene_or_gene_product"	"survivin	181	189	Gene_or_gene_product"	"p53	209	212	Gene_or_gene_product"	"murine double minute2	275	296	Gene_or_gene_product"	"MDM2	299	303	Gene_or_gene_product"	"[{""token"": ""p53"", ""start_span"": 28, ""end_span"": 31, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 57, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""luciferase"", ""start_span"": 77, ""end_span"": 87, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 138, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 167, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene_or_gene_product""}, {""token"": ""p53"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Gene_or_gene_product""}, {""token"": ""murine double minute2"", ""start_span"": 275, ""end_span"": 296, ""type"": ""Gene_or_gene_product""}, {""token"": ""MDM2"", ""start_span"": 299, ""end_span"": 303, ""type"": ""Gene_or_gene_product""}]"
To assess its role on human vascular lung development, we first examined the expression of IGF - I / II and IGF receptor type I ( IGF - IR) in human embryonic and fetal lung tissues at 4 - 12 wk of gestation.	"human	22	27	Organism"	"vascular	28	36	Multi"	"lung	37	41	Organ"	"IGF - I	91	98	Gene_or_gene_product"	"II	101	103	Gene_or_gene_product"	"IGF receptor type I	108	127	Gene_or_gene_product"	"IGF - IR	130	138	Gene_or_gene_product"	"human	143	148	Organism"	"embryonic	149	158	Tissue"	"fetal lung tissues	163	181	Tissue"	"[{""token"": ""human"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism""}, {""token"": ""vascular"", ""start_span"": 28, ""end_span"": 36, ""type"": ""Multi""}, {""token"": ""lung"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Organ""}, {""token"": ""IGF - I"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene_or_gene_product""}, {""token"": ""II"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF receptor type I"", ""start_span"": 108, ""end_span"": 127, ""type"": ""Gene_or_gene_product""}, {""token"": ""IGF - IR"", ""start_span"": 130, ""end_span"": 138, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Organism""}, {""token"": ""embryonic"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Tissue""}, {""token"": ""fetal lung tissues"", ""start_span"": 163, ""end_span"": 181, ""type"": ""Tissue""}]"
For this purpose, the presence of COX - 2 and PPARgamma was immunohistochemically examined in 71 epithelial ovarian carcinomas, 18 borderline tumours and 23 benign tumours and the levels of COX - 2 and PPARgamma proteins were determined by enzyme immunoassay in four benign tumours, three borderline tumours and 12 carcinomas.	"COX - 2	34	41	Gene_or_gene_product"	"PPARgamma	46	55	Gene_or_gene_product"	"epithelial ovarian carcinomas	97	126	Cancer"	"tumours	142	149	Cancer"	"tumours	164	171	Cancer"	"COX - 2	190	197	Gene_or_gene_product"	"PPARgamma	202	211	Gene_or_gene_product"	"tumours	274	281	Cancer"	"tumours	300	307	Cancer"	"carcinomas	315	325	Cancer"	"[{""token"": ""COX - 2"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 46, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""epithelial ovarian carcinomas"", ""start_span"": 97, ""end_span"": 126, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 164, ""end_span"": 171, ""type"": ""Cancer""}, {""token"": ""COX - 2"", ""start_span"": 190, ""end_span"": 197, ""type"": ""Gene_or_gene_product""}, {""token"": ""PPARgamma"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumours"", ""start_span"": 274, ""end_span"": 281, ""type"": ""Cancer""}, {""token"": ""tumours"", ""start_span"": 300, ""end_span"": 307, ""type"": ""Cancer""}, {""token"": ""carcinomas"", ""start_span"": 315, ""end_span"": 325, ""type"": ""Cancer""}]"
Here, we discuss the possibility for MMPs to contribute to pericyte recruitment at six levels: ( 1) direct promotion of pericyte invasion by extracellular matrix degradation; ( 2) stimulation of pericyte proliferation and protection against apoptosis by modification of the ECM; ( 3) activation of pericytes through the release of growth factor bound to the ECM; ( 4) transactivation of angiogenic cell surface receptor; ( 5) propagation of angiogenic signalling as cofactor; and ( 6) recruitment of bone marrow - derived stem cells.	"MMPs	37	41	Gene_or_gene_product"	"pericyte	59	67	Cell"	"pericyte	120	128	Cell"	"extracellular matrix	141	161	Cellular_component"	"pericyte	195	203	Cell"	"ECM	274	277	Cellular_component"	"pericytes	298	307	Cell"	"ECM	358	361	Cellular_component"	"cell surface	398	410	Cellular_component"	"bone marrow - derived stem cells	500	532	Cell"	"[{""token"": ""MMPs"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene_or_gene_product""}, {""token"": ""pericyte"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Cell""}, {""token"": ""pericyte"", ""start_span"": 120, ""end_span"": 128, ""type"": ""Cell""}, {""token"": ""extracellular matrix"", ""start_span"": 141, ""end_span"": 161, ""type"": ""Cellular_component""}, {""token"": ""pericyte"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Cell""}, {""token"": ""ECM"", ""start_span"": 274, ""end_span"": 277, ""type"": ""Cellular_component""}, {""token"": ""pericytes"", ""start_span"": 298, ""end_span"": 307, ""type"": ""Cell""}, {""token"": ""ECM"", ""start_span"": 358, ""end_span"": 361, ""type"": ""Cellular_component""}, {""token"": ""cell surface"", ""start_span"": 398, ""end_span"": 410, ""type"": ""Cellular_component""}, {""token"": ""bone marrow - derived stem cells"", ""start_span"": 500, ""end_span"": 532, ""type"": ""Cell""}]"
In fact, p75 ( NTR) depresses the VEGF - A / Akt / eNOS / NO pathway and additionally reduces the mRNA levels of ITGB1 [ beta ( 1) integrin], BIRC5 ( survivin), PTTG1 ( securin) and VEZF1.	"VEGF - A	34	42	Gene_or_gene_product"	"Akt	45	48	Gene_or_gene_product"	"eNOS	51	55	Gene_or_gene_product"	"NO	58	60	Chemical"	"ITGB1	113	118	Gene_or_gene_product"	"BIRC5	142	147	Gene_or_gene_product"	"survivin	150	158	Gene_or_gene_product"	"PTTG1	161	166	Gene_or_gene_product"	"securin	169	176	Gene_or_gene_product"	"VEZF1	182	187	Gene_or_gene_product"	"[{""token"": ""VEGF - A"", ""start_span"": 34, ""end_span"": 42, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene_or_gene_product""}, {""token"": ""eNOS"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene_or_gene_product""}, {""token"": ""NO"", ""start_span"": 58, ""end_span"": 60, ""type"": ""Chemical""}, {""token"": ""ITGB1"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene_or_gene_product""}, {""token"": ""BIRC5"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""survivin"", ""start_span"": 150, ""end_span"": 158, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTTG1"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene_or_gene_product""}, {""token"": ""securin"", ""start_span"": 169, ""end_span"": 176, ""type"": ""Gene_or_gene_product""}, {""token"": ""VEZF1"", ""start_span"": 182, ""end_span"": 187, ""type"": ""Gene_or_gene_product""}]"
Western blotting analysis showed that liposomal honokiol - inhibited Akt and MAPK phosphorylation in 2 endothelial cells, and downregulated expressions of VEGFR - 2 of human vascular endothelial cells and VEGFR - 3 of lymphatic endothelial cells.	"liposomal	38	47	Cellular_component"	"honokiol	48	56	Chemical"	"Akt	69	72	Gene_or_gene_product"	"MAPK	77	81	Gene_or_gene_product"	"endothelial cells	103	120	Cell"	"VEGFR - 2	155	164	Gene_or_gene_product"	"human	168	173	Organism"	"vascular endothelial cells	174	200	Cell"	"VEGFR - 3	205	214	Gene_or_gene_product"	"lymphatic endothelial cells	218	245	Cell"	"[{""token"": ""liposomal"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Cellular_component""}, {""token"": ""honokiol"", ""start_span"": 48, ""end_span"": 56, ""type"": ""Chemical""}, {""token"": ""Akt"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""MAPK"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 103, ""end_span"": 120, ""type"": ""Cell""}, {""token"": ""VEGFR - 2"", ""start_span"": 155, ""end_span"": 164, ""type"": ""Gene_or_gene_product""}, {""token"": ""human"", ""start_span"": 168, ""end_span"": 173, ""type"": ""Organism""}, {""token"": ""vascular endothelial cells"", ""start_span"": 174, ""end_span"": 200, ""type"": ""Cell""}, {""token"": ""VEGFR - 3"", ""start_span"": 205, ""end_span"": 214, ""type"": ""Gene_or_gene_product""}, {""token"": ""lymphatic endothelial cells"", ""start_span"": 218, ""end_span"": 245, ""type"": ""Cell""}]"
Rather, it has been hypothesized that, at low concentrations, MBDs produce more subtle effects on microtubule dynamics, block critical cell signaling pathways, and prevent the microtubules from properly interacting with transient subcellular assemblies ( focal adhesions and adherens junctions) whose subsequent stabilization and / or maturation are required for cell motility and cell - cell interactions.	"MBDs	62	66	Chemical"	"microtubule	98	109	Cellular_component"	"cell	135	139	Cell"	"microtubules	176	188	Cellular_component"	"subcellular assemblies	230	252	Cellular_component"	"focal adhesions	255	270	Cellular_component"	"adherens junctions	275	293	Cellular_component"	"cell	363	367	Cell"	"cell	381	385	Cell"	"cell	388	392	Cell"	"[{""token"": ""MBDs"", ""start_span"": 62, ""end_span"": 66, ""type"": ""Chemical""}, {""token"": ""microtubule"", ""start_span"": 98, ""end_span"": 109, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 135, ""end_span"": 139, ""type"": ""Cell""}, {""token"": ""microtubules"", ""start_span"": 176, ""end_span"": 188, ""type"": ""Cellular_component""}, {""token"": ""subcellular assemblies"", ""start_span"": 230, ""end_span"": 252, ""type"": ""Cellular_component""}, {""token"": ""focal adhesions"", ""start_span"": 255, ""end_span"": 270, ""type"": ""Cellular_component""}, {""token"": ""adherens junctions"", ""start_span"": 275, ""end_span"": 293, ""type"": ""Cellular_component""}, {""token"": ""cell"", ""start_span"": 363, ""end_span"": 367, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 381, ""end_span"": 385, ""type"": ""Cell""}, {""token"": ""cell"", ""start_span"": 388, ""end_span"": 392, ""type"": ""Cell""}]"
TSC2 and PTEN are two key inhibitors of the Akt / mammalian target of rapamycin ( mTOR) pathway and the specific inhibition of mTOR with rapamycin or RAD001 inhibited cell proliferation of PET cell lines.	"TSC2	0	4	Gene_or_gene_product"	"PTEN	9	13	Gene_or_gene_product"	"Akt	44	47	Gene_or_gene_product"	"mammalian target of rapamycin	50	79	Gene_or_gene_product"	"mTOR	82	86	Gene_or_gene_product"	"mTOR	127	131	Gene_or_gene_product"	"rapamycin	137	146	Chemical"	"RAD001	150	156	Chemical"	"cell	167	171	Cell"	"PET cell lines	189	203	Cell"	"[{""token"": ""TSC2"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene_or_gene_product""}, {""token"": ""PTEN"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Gene_or_gene_product""}, {""token"": ""Akt"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Gene_or_gene_product""}, {""token"": ""mammalian target of rapamycin"", ""start_span"": 50, ""end_span"": 79, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene_or_gene_product""}, {""token"": ""mTOR"", ""start_span"": 127, ""end_span"": 131, ""type"": ""Gene_or_gene_product""}, {""token"": ""rapamycin"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Chemical""}, {""token"": ""RAD001"", ""start_span"": 150, ""end_span"": 156, ""type"": ""Chemical""}, {""token"": ""cell"", ""start_span"": 167, ""end_span"": 171, ""type"": ""Cell""}, {""token"": ""PET cell lines"", ""start_span"": 189, ""end_span"": 203, ""type"": ""Cell""}]"
Ectopic expression of TLX in the U87MG glioma cell line and Ink4a / Arf - deficient mouse astrocytes ( Ink4a / Arf ( - / -) astrocytes) induced cell proliferation with a concomitant increase in cyclin D expression, and accelerated foci formation in soft agar and tumor formation in in vivo transplantation assays.	"TLX	22	25	Gene_or_gene_product"	"U87MG glioma cell line	33	55	Cell"	"Ink4a	60	65	Gene_or_gene_product"	"Arf	68	71	Gene_or_gene_product"	"Ink4a	103	108	Gene_or_gene_product"	"Arf	111	114	Gene_or_gene_product"	"cell	144	148	Cell"	"cyclin D	194	202	Gene_or_gene_product"	"foci	231	235	Cell"	"tumor	263	268	Cancer"	"[{""token"": ""TLX"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Gene_or_gene_product""}, {""token"": ""U87MG glioma cell line"", ""start_span"": 33, ""end_span"": 55, ""type"": ""Cell""}, {""token"": ""Ink4a"", ""start_span"": 60, ""end_span"": 65, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 68, ""end_span"": 71, ""type"": ""Gene_or_gene_product""}, {""token"": ""Ink4a"", ""start_span"": 103, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""Arf"", ""start_span"": 111, ""end_span"": 114, ""type"": ""Gene_or_gene_product""}, {""token"": ""cell"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Cell""}, {""token"": ""cyclin D"", ""start_span"": 194, ""end_span"": 202, ""type"": ""Gene_or_gene_product""}, {""token"": ""foci"", ""start_span"": 231, ""end_span"": 235, ""type"": ""Cell""}, {""token"": ""tumor"", ""start_span"": 263, ""end_span"": 268, ""type"": ""Cancer""}]"
The apparent mesenchymal to epithelial conversion of the tumor cells mimics the conversion that occurs during embryonic kidney development, suggesting that Met - HGF / SF signaling plays a role in this process as well as in tumors that express both epithelial and mesenchymal markers.	"mesenchymal	13	24	Cell"	"epithelial	28	38	Cell"	"tumor cells	57	68	Cell"	"embryonic kidney	110	126	Organ"	"Met	156	159	Gene_or_gene_product"	"HGF	162	165	Gene_or_gene_product"	"SF	168	170	Gene_or_gene_product"	"tumors	224	230	Cancer"	"epithelial	249	259	Cell"	"mesenchymal	264	275	Cell"	"[{""token"": ""mesenchymal"", ""start_span"": 13, ""end_span"": 24, ""type"": ""Cell""}, {""token"": ""epithelial"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Cell""}, {""token"": ""tumor cells"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Cell""}, {""token"": ""embryonic kidney"", ""start_span"": 110, ""end_span"": 126, ""type"": ""Organ""}, {""token"": ""Met"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Gene_or_gene_product""}, {""token"": ""HGF"", ""start_span"": 162, ""end_span"": 165, ""type"": ""Gene_or_gene_product""}, {""token"": ""SF"", ""start_span"": 168, ""end_span"": 170, ""type"": ""Gene_or_gene_product""}, {""token"": ""tumors"", ""start_span"": 224, ""end_span"": 230, ""type"": ""Cancer""}, {""token"": ""epithelial"", ""start_span"": 249, ""end_span"": 259, ""type"": ""Cell""}, {""token"": ""mesenchymal"", ""start_span"": 264, ""end_span"": 275, ""type"": ""Cell""}]"
Murine leukemia L1210 cells rendered deficient in glutathione peroxidase ( GPX) and phospholipid hydroperoxide glutathione peroxidase ( PHGPX) by Se deprivation ( L. Se ( -) cells) were found to be more sensitive to tert - butyl hydroperoxide ( t - BuOOH) cytotoxicity than Se - replete controls ( L. Se ( +) cells).	"Murine	0	6	Organism"	"leukemia L1210 cells	7	27	Cell"	"glutathione peroxidase	50	72	Gene_or_gene_product"	"GPX	75	78	Gene_or_gene_product"	"phospholipid hydroperoxide glutathione peroxidase	84	133	Gene_or_gene_product"	"PHGPX	136	141	Gene_or_gene_product"	"Se	146	148	Chemical"	"tert - butyl hydroperoxide	216	242	Chemical"	"t - BuOOH	245	254	Chemical"	"Se	274	276	Chemical"	"[{""token"": ""Murine"", ""start_span"": 0, ""end_span"": 6, ""type"": ""Organism""}, {""token"": ""leukemia L1210 cells"", ""start_span"": 7, ""end_span"": 27, ""type"": ""Cell""}, {""token"": ""glutathione peroxidase"", ""start_span"": 50, ""end_span"": 72, ""type"": ""Gene_or_gene_product""}, {""token"": ""GPX"", ""start_span"": 75, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""phospholipid hydroperoxide glutathione peroxidase"", ""start_span"": 84, ""end_span"": 133, ""type"": ""Gene_or_gene_product""}, {""token"": ""PHGPX"", ""start_span"": 136, ""end_span"": 141, ""type"": ""Gene_or_gene_product""}, {""token"": ""Se"", ""start_span"": 146, ""end_span"": 148, ""type"": ""Chemical""}, {""token"": ""tert - butyl hydroperoxide"", ""start_span"": 216, ""end_span"": 242, ""type"": ""Chemical""}, {""token"": ""t - BuOOH"", ""start_span"": 245, ""end_span"": 254, ""type"": ""Chemical""}, {""token"": ""Se"", ""start_span"": 274, ""end_span"": 276, ""type"": ""Chemical""}]"
Many cellular and biochemical effects of curcumin in mouse fibroblast cells have been reported, such as inhibition of protein kinase C ( PKC) activity induced by phorbol 12 - myristate 13 - acetate treatment, inhibition of tyrosine protein kinase activity, and inhibition of arachidonic acid ( AA) metabolism.	"cellular	5	13	Cell"	"curcumin	41	49	Chemical"	"mouse	53	58	Organism"	"fibroblast cells	59	75	Cell"	"protein kinase C	118	134	Gene_or_gene_product"	"PKC	137	140	Gene_or_gene_product"	"phorbol 12 - myristate 13 - acetate	162	197	Chemical"	"tyrosine	223	231	Amino_acid"	"arachidonic acid	275	291	Chemical"	"AA	294	296	Chemical"	"[{""token"": ""cellular"", ""start_span"": 5, ""end_span"": 13, ""type"": ""Cell""}, {""token"": ""curcumin"", ""start_span"": 41, ""end_span"": 49, ""type"": ""Chemical""}, {""token"": ""mouse"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Organism""}, {""token"": ""fibroblast cells"", ""start_span"": 59, ""end_span"": 75, ""type"": ""Cell""}, {""token"": ""protein kinase C"", ""start_span"": 118, ""end_span"": 134, ""type"": ""Gene_or_gene_product""}, {""token"": ""PKC"", ""start_span"": 137, ""end_span"": 140, ""type"": ""Gene_or_gene_product""}, {""token"": ""phorbol 12 - myristate 13 - acetate"", ""start_span"": 162, ""end_span"": 197, ""type"": ""Chemical""}, {""token"": ""tyrosine"", ""start_span"": 223, ""end_span"": 231, ""type"": ""Amino_acid""}, {""token"": ""arachidonic acid"", ""start_span"": 275, ""end_span"": 291, ""type"": ""Chemical""}, {""token"": ""AA"", ""start_span"": 294, ""end_span"": 296, ""type"": ""Chemical""}]"
